SCWorx Announces Resumption of Nasdaq Trading and Highlights Improved Operating Performance and Growth Strategy
SCWorx's common stock resumed trading on the Nasdaq Capital Market after the Nasdaq Hearings Panel granted reconsideration of its September 17 delisting decision and found the company back in compliance. Continued listing is subject to conditions including a one-year Panel Monitor, during which any new deficiency would trigger a delisting determination with no cure period. Operationally, Q2 2026 revenue was ~$706,000 (up from ~$683,000), gross profit rose ~83% to ~$330,000, and the net loss narrowed to ~$121,000 from ~$1.9 million a year ago.
Key figures
- Revenue
- 706000
- Guidance
- No formal guidance; management targets recurring revenue growth, improved margins and positive cash flow
- Revenue Yoy
- approximately 3% (Q2 2026 ~$706,000 vs ~$683,000 in Q2 2025)
- H1 2026 revenue
- ~$1.45 million vs ~$1.40 million prior year
- Q2 gross profit
- $330,000, up ~83% YoY
- H1 2026 net loss
- ~$295,000 vs ~$2.4 million prior year
- Q2 2026 net loss
- ~$121,000 vs ~$1.9 million prior year
- Cash at june 30 2026
- ~$1.3 million
- H1 2026 gross profit
- $705,000, up ~122% YoY
- H1 2026 operating cash use
- ~$258,000 vs ~$1.1 million prior year
- September 2026 private placement
- $938,000 gross proceeds
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.